Deepika Pakianathan is Director of PARDES BIOSCIENCES, INC.. Currently has a direct ownership of 52,500 shares of PRDS, which is worth approximately $0. The most recent transaction as insider was on Dec 23, 2021, when has been sold 52,500 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.5K
0% 3M change
0% 12M change
Total Value Held $0

DEEPIKA PAKIANATHAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2021
BUY
Conversion of derivative security
-
52,500 Added 50.0%
52,500 Class A Common Stock

Also insider at

TBPH
Theravance Biopharma, Inc. Healthcare
KPTI
Karyopharm Therapeutics Inc. Healthcare
CALA
Calithera Biosciences, Inc. Healthcare
MREO
Mereo Biopharma Group plc Healthcare
DP

Deepika Pakianathan

Director
South San Francisco, CA

Track Institutional and Insider Activities on PRDS

Follow PARDES BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRDS shares.

Notify only if

Insider Trading

Get notified when an Pardes Biosciences, Inc. insider buys or sells PRDS shares.

Notify only if

News

Receive news related to PARDES BIOSCIENCES, INC.

Track Activities on PRDS